Quantcast
Home / Practice Areas / Business and Civil Practice / Justices to rule on preemption of drug design defect claims

Justices to rule on preemption of drug design defect claims

The U.S. Supreme Court has agreed to decide whether federal law preempts state law design defect claims targeting generic pharmaceutical products.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top